Showing results (171-180 of 216) with videos related to
Sort By:
Pageof 22
Epilepsy & Behavior : E&B|January 22, 2019
Effect of sleep quality on memory, executive function, and language performance in patients with refractory focal epilepsy and controlled epilepsy versus healthy controls - A prospective studyKamalesh Chakravarty, Garima Shukla, Shivani Poornima, et al.Plos One|February 20, 2016
Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in IndiaUrvashi B Singh, Pooja Pandey, Girija Mehta, et al.Neuropsychiatric Disease and Treatment|October 22, 2019
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson's Disease And SchizophreniaAshish Kumar Gupta, Ruchika Pokhriyal, Mohd Imran Khan, et al.Epilepsy & Behavior : E&B|August 24, 2010
Study of DSM-IV Axis I psychiatric disorders in patients with refractory complex partial seizures using a short structured clinical interviewSoaham D Desai, Garima Shukla, Vinay Goyal, et al.Journal of Movement Disorders|February 17, 2025
CSF1R-Related Adult-Onset Leukoencephalopathy With Axonal Spheroids: A Case Series of Four Asian Indian PatientsDivyani Garg, Abhishek Vaingankar, Anu Gupta, et al.Journal of Personalized Medicine|August 6, 2021
Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable SensorsVinod Metta, Lucia Batzu, Valentina Leta, et al.Neurology India|June 16, 2023
Rivastigmine for Cognitive Impairment in Multiple Sclerosis: A Prospective Randomized Open Label study with Blinded End-Point AssessmentAmrita J Gotur, Kameshwar Prasad, Rohit Bhatia, et al.Seizure|November 20, 2015
Lateralizing value of unilateral relative ictal immobility in patients with refractory focal seizures--Looking beyond unilateral automatismsPriya Agarwal, Bhavna Kaul, Garima Shukla, et al.Neuropsychiatric Disease and Treatment|August 15, 2019
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophreniaAshish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, et al.Journal of Personalized Medicine|May 27, 2023
Hiccups, Hypersalivation, Hallucinations in Parkinson's Disease: New Insights, Mechanisms, Pathophysiology, and ManagementVinod Metta, Guy Chung-Faye, Hani Ts Benamer, et al.Pageof 22